GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 20, 2020

Primary Completion Date

May 20, 2020

Study Completion Date

May 20, 2020

Conditions
Gestational Diabetes
Interventions
DIAGNOSTIC_TEST

Serum amyloid A values

Women who are diagnosed with GDM between the ages of 18 and 43 will receive blood in the biochemistry tube. This tube will then be centrifuged. A-SAA and IL-1Ra levels will be checked by ELISA method in serum stored at -80 degrees.

DIAGNOSTIC_TEST

Interleukin-1 (IL-1) receptor antagonist values (A-SAA and IL-1Ra)

Women who are diagnosed with GDM between the ages of 18 and 43 will receive blood in the biochemistry tube. This tube will then be centrifuged. A-SAA and IL-1Ra levels will be checked by ELISA method in serum stored at -80 degrees.

Trial Locations (1)

33404

Kanuni Sultan Süleyman Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT04238936 - GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist | Biotech Hunter | Biotech Hunter